• ABOUT
Product description
1.
Hardware
a. Light-sources for high-field NMR
b. Light-coupled benchtop NMR
Implement light-coupled NMR to gain 100-fold faster measurements
2.
Consumables
a. Ultrafast NMR Fragment library
b. Ultrafast NMR reagents kit
Reduce NMR sample preparation time and optimize performances
3.
Software
a. Automated screening analysis
b. Automated affinity determination analysis
Ultrafast and automated data analysis
NexMR build upon a
team of experts
NexMR is an ETH Zurich spin-off offering key-in-hands solutions to improve the throughput and optimize the resources of NMR-drug discovery pipelines.
NexMR’s technology is designed to address challenging targets
• ADVANTAGES
Address your drug discovery
challenges with NexMR
——
Early stage drug discovery
——
Sensitivity-enhanced NMR accelerate experimental turnaround
——
Determine hit affinities by NMR with Isotope labelling
——
Information at the atomic scale
Faster
30-50-fold
Cheaper
Compatible with benchtop NMR
Simpler
Designed for lab technicians
Economical
Reduce sample concentration by 10-100-fold
About founders
Dr Félix
Torres
CEO
Felix is a PharmD and PhD in Chemistry from ETH Zürich. He developed tools for structural biology and drug discovery for the last 7 years.
Dr Matthias Bütikofer
CSO
Matthias is a MSc in chemistry from ETH Zürich. He is also a lab expert with experience working at the chemistry department of Roche.
Prof Roland
Riek
Scientific Advisor
Roland is a tenured Prof at ETH Zürich. His work pioneered the study of biomolecules by NMR in particular amyloid fibrils.
Anil
Sethi
Board Member
Anil is a serial entrepreneur, author and academic. He is also an advisor toa number of technology startups.
• CONTACT US
Interested in our
services?
You fill out an application on the website
We will contact you within 1-2 business days
After discussion, we offer you a solution adapted to your needs!
